Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Citigroup Downgrades Meredith to Neutral, Raises Price Target to $59

Author: Benzinga Newsdesk | October 08, 2021 08:09am
Citigroup analyst Jason Bazinet downgrades Meredith (NYSE:MDP) from Buy to Neutral and raises the price target from $54 to $59.

Posted In: MDP

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist